Olympiad Research LP acquired a new position in shares of Leidos Holdings, Inc. (NYSE:LDOS – Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,917 shares of the aerospace company’s stock, valued at approximately $312,000.
Several other hedge funds also recently made changes to their positions in the company. Boston Partners grew its position in shares of Leidos by 5.8% in the 1st quarter. Boston Partners now owns 3,430,264 shares of the aerospace company’s stock worth $449,592,000 after acquiring an additional 188,458 shares in the last quarter. Millennium Management LLC boosted its position in Leidos by 156.5% during the 2nd quarter. Millennium Management LLC now owns 1,133,508 shares of the aerospace company’s stock valued at $165,356,000 after purchasing an additional 691,575 shares during the period. Allspring Global Investments Holdings LLC boosted its position in Leidos by 51.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 837,370 shares of the aerospace company’s stock valued at $136,491,000 after purchasing an additional 283,558 shares during the period. Panagora Asset Management Inc. boosted its position in Leidos by 39.7% during the 2nd quarter. Panagora Asset Management Inc. now owns 782,161 shares of the aerospace company’s stock valued at $114,102,000 after purchasing an additional 222,179 shares during the period. Finally, AQR Capital Management LLC boosted its position in Leidos by 76.9% during the 2nd quarter. AQR Capital Management LLC now owns 698,807 shares of the aerospace company’s stock valued at $101,942,000 after purchasing an additional 303,775 shares during the period. Institutional investors and hedge funds own 76.12% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the company. The Goldman Sachs Group boosted their price objective on Leidos from $205.00 to $228.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th. Barclays boosted their price objective on Leidos from $165.00 to $210.00 and gave the company an “overweight” rating in a research report on Monday. Royal Bank of Canada boosted their price objective on Leidos from $145.00 to $180.00 and gave the company a “sector perform” rating in a research report on Wednesday, October 30th. TD Cowen boosted their price target on Leidos from $175.00 to $200.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Finally, Wells Fargo & Company boosted their price target on Leidos from $183.00 to $230.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 30th. Two research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $191.23.
Insider Activity
In other news, Director Gary Stephen May sold 1,000 shares of Leidos stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $144.02, for a total transaction of $144,020.00. Following the transaction, the director now owns 11,264 shares in the company, valued at approximately $1,622,241.28. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Leidos news, Director Gary Stephen May sold 1,000 shares of the business’s stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $144.02, for a total value of $144,020.00. Following the transaction, the director now owns 11,264 shares in the company, valued at $1,622,241.28. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the company’s stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $184.94, for a total value of $193,632.18. Following the sale, the director now owns 6,408 shares of the company’s stock, valued at approximately $1,185,095.52. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.96% of the stock is currently owned by corporate insiders.
Leidos Stock Down 0.8 %
LDOS opened at $192.63 on Friday. Leidos Holdings, Inc. has a one year low of $102.21 and a one year high of $198.99. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.15 and a current ratio of 1.23. The stock’s fifty day moving average is $165.11 and its 200-day moving average is $152.75. The company has a market capitalization of $25.70 billion, a PE ratio of 21.94, a P/E/G ratio of 1.48 and a beta of 0.68.
Leidos (NYSE:LDOS – Get Free Report) last announced its earnings results on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.96 by $0.97. The company had revenue of $4.19 billion for the quarter, compared to analyst estimates of $4.06 billion. Leidos had a return on equity of 30.31% and a net margin of 7.37%. Leidos’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.03 earnings per share. On average, equities analysts predict that Leidos Holdings, Inc. will post 10.07 EPS for the current fiscal year.
Leidos Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Monday, December 16th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, December 13th. This is a positive change from Leidos’s previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.83%. Leidos’s payout ratio is 17.31%.
Leidos Company Profile
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
See Also
- Five stocks we like better than Leidos
- What is a support level?
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Using the MarketBeat Dividend Tax Calculator
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Top Biotech Stocks: Exploring Innovation Opportunities
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.